Helmut Mett
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Polyamine Metabolism and Applications 13
- PI3K/AKT/mTOR signaling in cancer 10
- Protein Kinase Regulation and GTPase Signaling 5
- Biochemical and Molecular Research 5
- Oncology 15
- HER2/EGFR in Cancer Research 11
- Co-authors
- Thomas Meyer (17 shared papers)Elisabeth Buchdunger (13 shared papers)Nicholas Lydon (12 shared papers)J. Zimmermann (7 shared papers)Marcel Müller (3 shared papers)Brian Druker (1 shared paper)Pascal Furet (10 shared papers)Peter Traxler (10 shared papers)
- Journals
- Journal of Medicinal Chemistry (8 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)Helvetica Chimica Acta (3 papers)The Journal of Antibiotics (3 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Helmut Mett
57 papers receiving 3.2k citations
Helmut Mett's Hit Papers
Peers
Comparison fields: 5 of 111
- Hematology 840
- Genetics 502
- Biochemistry 195
- Oncology 615
- Organic Chemistry 723
Countries citing papers authored by Helmut Mett
This map shows the geographic impact of Helmut Mett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helmut Mett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helmut Mett more than expected).
Fields of papers citing papers by Helmut Mett
This network shows the impact of papers produced by Helmut Mett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helmut Mett. The network helps show where Helmut Mett may publish in the future.
Co-authors
The 25 scholars most cited alongside Helmut Mett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Hit paper breakdown → | 1996 | 878 |
| 2 | 1995 | 243 | |
| 3 | 1997 | 185 | |
| 4 | 1997 | 179 | |
| 5 | 1996 | 134 | |
| 6 | 1999 | 122 | |
| 7 | 1996 | 105 | |
| 8 | CGP 48664, a new S-adenosylmethionine decarboxylase inhibitor with broad spectrum antiproliferative and antitumor activity. | 1994 | 96 |
| 9 | 1999 | 90 | |
| 10 | 1999 | 74 | |
| 11 | 1994 | 74 | |
| 12 | 1997 | 73 | |
| 13 | 1995 | 72 | |
| 14 | 1988 | 64 | |
| 15 | 1996 | 60 | |
| 16 | New S-adenosylmethionine decarboxylase inhibitors with potent antitumor activity. | 1992 | 49 |
| 17 | 1994 | 48 | |
| 18 | 1996 | 47 | |
| 19 | 1993 | 46 | |
| 20 | 1995 | 45 |
About Helmut Mett
Helmut Mett is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pharmacology and Biochemistry, having authored 59 papers that have together received 3.3k indexed citations. Recurring topics across this work include Polyamine Metabolism and Applications (13 papers), HER2/EGFR in Cancer Research (11 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), Quinazolinone synthesis and applications (8 papers), Amino Acid Enzymes and Metabolism (7 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Biochemical and Molecular Research (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Hematology (840 citations), Genetics (502 citations), Biochemistry (195 citations), Oncology (615 citations) and Organic Chemistry (723 citations). Helmut Mett has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Thomas Meyer, Elisabeth Buchdunger, Nicholas Lydon, J. Zimmermann, Marcel Müller, Brian Druker, Pascal Furet, Peter Traxler, Urs Regenass and Marcel Mueller. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Antimicrobial Agents and Chemotherapy, Helvetica Chimica Acta and The Journal of Antibiotics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.